Peri-operative biology in primary breast cancer: a credible therapeutic target Richard R. LoveSusan M. Love Review 24 March 2016 Pages: 411 - 413
Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions Claire JohnsSusan M. SeavH. Irene Su Review 26 March 2016 Pages: 415 - 426
Neoadjuvant nab-paclitaxel in the treatment of breast cancer Naoto T. UenoEleftherios P. Mamounas Review Open access 12 April 2016 Pages: 427 - 440
Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations Lu YaoJie SunYuntao Xie Preclinical study 31 March 2016 Pages: 441 - 445
SEARCHBreast: a new resource to locate and share surplus archival material from breast cancer animal models to help address the 3Rs Karen BlythPhil CarterValerie Speirs Preclinical study Open access 15 April 2016 Pages: 447 - 452
Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer Heather GreenleeKatherine D. CrewDawn L. Hershman Clinical trial 25 March 2016 Pages: 453 - 464
Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study Lori M. van RoozendaalLeonie H. M. SmitMarjolein L. Smidt Clinical trial Open access 25 March 2016 Pages: 465 - 472
Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population Seung Taek LimJung Eun ChoiYoung Jin Suh Clinical trial 04 April 2016 Pages: 473 - 483
Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry Takayuki IwamotoHiraku KumamaruYutaka Tokuda Clinical trial Open access 05 April 2016 Pages: 485 - 494
Structured reporting ensures complete content and quick detection of essential data in pathology reports of oncological breast resection specimens Konrad AumannKathrin NiermannMartin Werner Clinical trial 08 April 2016 Pages: 495 - 500
Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up G. MurtaghT. LyonsJ. M. Walshe Clinical trial 09 April 2016 Pages: 501 - 506
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial Milagros González-RiveraMiriam LoboMiguel Martin Clinical trial 15 April 2016 Pages: 507 - 515
Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy L. M. van RoozendaalB. GoortsM. L. Smidt Clinical trial Open access 15 April 2016 Pages: 517 - 525
High use of complementary and alternative medicine among a large cohort of women with a family history of breast cancer: the Sister Study Heather GreenleeChristine L. Sardo MolmentiDale P. Sandler Epidemiology 26 March 2016 Pages: 527 - 538
Prognostic factors in male breast cancer: a population-based study José Pablo LeoneAriel Osvaldo ZwengerRohit Bhargava Epidemiology 02 April 2016 Pages: 539 - 548
Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy Chalanda N. EvansNoel T. BrewerSuzanne C. O’Neill Epidemiology 08 April 2016 Pages: 549 - 555
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer Jan C. DroogerBernadette A. M. Heemskerk-GerritsenAgnes Jager Epidemiology Open access 09 April 2016 Pages: 557 - 566
Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls Kathy PanRowan T. ChlebowskiElectra D. Paskett Epidemiology 13 April 2016 Pages: 567 - 576
Prediction of long-term cumulative incidences based on short-term parametric model for competing risks: application in early breast cancer B. CabarrouL. BelinT. Filleron Epidemiology 13 April 2016 Pages: 577 - 585
The incidence of bone metastasis after early-stage breast cancer in Canada Alexander LiedeKatarzyna J. JerzakSteven A. Narod Epidemiology 15 April 2016 Pages: 587 - 595
MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer Young-Ae KimHee Jin LeeGyungyub Gong Brief Report 13 April 2016 Pages: 597 - 606
Erratum to: A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer Sepideh GholamiAndrew MaranoYuman Fong Erratum 30 March 2016 Pages: 607 - 608
Erratum to: FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells Juan DuLin LiJun Lu Erratum 08 April 2016 Pages: 609 - 610